Baxalta IncorporatedBXLT is the latest company to join the race for biosimilars. The company along with Momenta Pharmaceuticals, Inc. MNTA announced the commencement of a pivotal study on their biosimilar candidate, M923, in patients suffering from chronic plaque psoriasis.
Baxalta, Momenta Begin Pivotal Study on Biosimilar of Humira
